Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2013-07-09 16:18:47 UTC |
---|
Update Date | 2021-09-14 14:57:39 UTC |
---|
HMDB ID | HMDB0061105 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | ortho-hydroxyrosiglitazone |
---|
Description | ortho-hydroxyrosiglitazone is a metabolite of rosiglitazone. Rosiglitazone is an antidiabetic drug in the thiazolidinedione class of drugs. It works as an insulin sensitizer, by binding to the PPAR receptors in fat cells and making the cells more responsive to insulin. It is marketed by the pharmaceutical company GlaxoSmithKline (GSK) as a stand-alone drug (Avandia) and in combination with metformin (Avandamet) or with glimepiride (Avandaryl). Annual sales peaked at approximately $2.5bn in 2006, but declined after reports of adverse effects. (Wikipedia) |
---|
Structure | CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=C(O)C=CC=N1 InChI=1S/C18H19N3O4S/c1-21(16-14(22)3-2-8-19-16)9-10-25-13-6-4-12(5-7-13)11-15-17(23)20-18(24)26-15/h2-8,15,22H,9-11H2,1H3,(H,20,23,24) |
---|
Synonyms | Not Available |
---|
Chemical Formula | C18H19N3O4S |
---|
Average Molecular Weight | 373.426 |
---|
Monoisotopic Molecular Weight | 373.109626801 |
---|
IUPAC Name | 4-hydroxy-5-[(4-{2-[(3-hydroxypyridin-2-yl)(methyl)amino]ethoxy}phenyl)methyl]-2,5-dihydro-1,3-thiazol-2-one |
---|
Traditional Name | 4-hydroxy-5-[(4-{2-[(3-hydroxypyridin-2-yl)(methyl)amino]ethoxy}phenyl)methyl]-5H-1,3-thiazol-2-one |
---|
CAS Registry Number | Not Available |
---|
SMILES | CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=C(O)C=CC=N1 |
---|
InChI Identifier | InChI=1S/C18H19N3O4S/c1-21(16-14(22)3-2-8-19-16)9-10-25-13-6-4-12(5-7-13)11-15-17(23)20-18(24)26-15/h2-8,15,22H,9-11H2,1H3,(H,20,23,24) |
---|
InChI Key | KQXWMUFVDAFGPU-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Phenol ethers |
---|
Sub Class | Not Available |
---|
Direct Parent | Phenol ethers |
---|
Alternative Parents | |
---|
Substituents | - Phenoxy compound
- Phenol ether
- Dialkylarylamine
- Alkyl aryl ether
- Aminopyridine
- Hydroxypyridine
- Monocyclic benzene moiety
- Pyridine
- Imidolactam
- Heteroaromatic compound
- Meta-thiazoline
- Carbonic acid derivative
- Ether
- Azacycle
- Organoheterocyclic compound
- Propargyl-type 1,3-dipolar organic compound
- Organic 1,3-dipolar compound
- Organooxygen compound
- Organonitrogen compound
- Organic oxide
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxygen compound
- Organopnictogen compound
- Carbonyl group
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
ortho-hydroxyrosiglitazone,1TMS,isomer #1 | CN(CCOC1=CC=C(CC2SC(=O)N=C2O[Si](C)(C)C)C=C1)C1=NC=CC=C1O | 3448.5 | Semi standard non polar | 33892256 | ortho-hydroxyrosiglitazone,1TMS,isomer #2 | CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=NC=CC=C1O[Si](C)(C)C | 3529.8 | Semi standard non polar | 33892256 | ortho-hydroxyrosiglitazone,2TMS,isomer #1 | CN(CCOC1=CC=C(CC2SC(=O)N=C2O[Si](C)(C)C)C=C1)C1=NC=CC=C1O[Si](C)(C)C | 3450.4 | Semi standard non polar | 33892256 | ortho-hydroxyrosiglitazone,1TBDMS,isomer #1 | CN(CCOC1=CC=C(CC2SC(=O)N=C2O[Si](C)(C)C(C)(C)C)C=C1)C1=NC=CC=C1O | 3677.9 | Semi standard non polar | 33892256 | ortho-hydroxyrosiglitazone,1TBDMS,isomer #2 | CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=NC=CC=C1O[Si](C)(C)C(C)(C)C | 3742.0 | Semi standard non polar | 33892256 | ortho-hydroxyrosiglitazone,2TBDMS,isomer #1 | CN(CCOC1=CC=C(CC2SC(=O)N=C2O[Si](C)(C)C(C)(C)C)C=C1)C1=NC=CC=C1O[Si](C)(C)C(C)(C)C | 3794.8 | Semi standard non polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - ortho-hydroxyrosiglitazone GC-MS (Non-derivatized) - 70eV, Positive | splash10-05g0-4932000000-7da5f4e50b59ced3de23 | 2017-09-20 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - ortho-hydroxyrosiglitazone GC-MS (2 TMS) - 70eV, Positive | splash10-0ue9-4692150000-00d6fad719ebbe3a8e5d | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - ortho-hydroxyrosiglitazone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - ortho-hydroxyrosiglitazone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - ortho-hydroxyrosiglitazone 10V, Positive-QTOF | splash10-00di-0219000000-9ee1246f5606ccba338c | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - ortho-hydroxyrosiglitazone 20V, Positive-QTOF | splash10-0udi-0925000000-f2f1a0547338d02c0277 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - ortho-hydroxyrosiglitazone 40V, Positive-QTOF | splash10-0a70-1910000000-5d149c7a5cc9dd4d2862 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - ortho-hydroxyrosiglitazone 10V, Negative-QTOF | splash10-00di-0229000000-0ff802c62bbd3068bda8 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - ortho-hydroxyrosiglitazone 20V, Negative-QTOF | splash10-0ukc-6897000000-69fdd4c434bd3e0ba13a | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - ortho-hydroxyrosiglitazone 40V, Negative-QTOF | splash10-0006-9400000000-bca081c8bd3472d80bfc | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - ortho-hydroxyrosiglitazone 10V, Negative-QTOF | splash10-00di-0249000000-d04dabe572ac1289c09d | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - ortho-hydroxyrosiglitazone 20V, Negative-QTOF | splash10-006x-6439000000-7c379ffdf2b141c6831f | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - ortho-hydroxyrosiglitazone 40V, Negative-QTOF | splash10-0006-9100000000-b942da07d15082e7d035 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - ortho-hydroxyrosiglitazone 10V, Positive-QTOF | splash10-00di-0509000000-b4dd5bd16cdf97320c49 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - ortho-hydroxyrosiglitazone 20V, Positive-QTOF | splash10-0uk9-0529000000-2e508890ecaecaa5e4b1 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - ortho-hydroxyrosiglitazone 40V, Positive-QTOF | splash10-0kar-0911000000-9c742637b9b75e231d32 | 2021-09-23 | Wishart Lab | View Spectrum |
|
---|